Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors
about
Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6.Cancer diagnosis marker extraction for soft tissue sarcomas based on gene expression profiling data by using projective adaptive resonance theory (PART) filtering method.Hematopoietic gene expression profile in zebrafish kidney marrow.Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy.Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomideReduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastomaNear-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocationMolecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemiaMLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomLeukemias related to treatment with DNA topoisomerase II inhibitors.Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.Early Detection of t(8;21) Chromosomal Translocations During Treatment of PML-RARA Positive Acute Promyelocytic Leukemia: A Case StudySecond cancers in survivors of childhood cancer.Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes.Molecular pathogenesis of secondary acute promyelocytic leukemiaPremature transcript termination, trans-splicing and DNA repair: a vicious path to cancer.The biological and clinical significance of MLL abnormalities in haematological malignancies.Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature.Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndromeCancer genetics of epigenetic genes.Gas7 is required for mesenchymal stem cell-derived bone development.Do non-genomically encoded fusion transcripts cause recurrent chromosomal translocations?Therapy-related myelodysplasia and acute myeloid leukemiaCytogenetic instability in childhood acute lymphoblastic leukemia survivors.Epigenetic alterations in hematopoietic malignancies.Coexistence of treatment-related MLL cleavage and rearrangement in a child with haemophagocytic lymphohistiocytosisPreferential induction of MLL(Mixed Lineage Leukemia) rearrangements in human lymphocyte cultures treated with etoposide.Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processEffects of topoisomerase 2 inhibitors on the MLL gene in children receiving chemotherapy: a prospective study.Acute lymphoblastic leukemia secondary to chemoradiotherapy for perivascular epithelioid cell tumor of uterus.Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma.From initiation to eradication: the lifespan of an MLL-rearranged therapy-related paediatric AML.The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21).
P2860
Q24536146-C4D5735D-5455-469E-880E-9C6B40F57695Q31058622-2B576219-8FC1-492E-B39B-ACADB2E6C2DBQ33208596-064522E4-CAD0-4688-B176-5A563383044AQ33210267-7A1357F1-4451-421B-BA70-B4BF1EDF0863Q33566420-36D615FC-CC25-4656-8836-8144DFCC3888Q33836091-F28E3247-419B-4B77-BD43-2A7917818028Q33933823-5B873448-45C4-4722-A020-A1D52851BB89Q33943185-8EB9B1C2-51EC-42C8-A644-34BF379833E4Q34136814-3B4DC061-30F7-49F2-911D-556A6F39D6D4Q34243503-5E8A61CF-499B-4C94-A0DB-278CD6BC07D7Q34405465-E0AAFAB8-4396-4A3A-9513-A68F692C0763Q34480479-3047C111-380F-4798-8382-61B0323ED852Q35084794-1258ACD0-4E50-4319-9010-93A135A3AC1EQ35209776-73DB3807-778C-4666-9C1E-95FAB937899EQ35560260-55B360E9-7AE2-420B-9FAD-04E3E9C34B94Q35824956-D1047A2B-9AE7-4D73-B052-D45E96403D33Q35854955-CF594EC1-E512-4EBD-8745-E707F31A9528Q36090310-BF3C9CE5-354D-42BB-B0EC-0519AEDEE53DQ36508959-7E438F98-4DF2-49A4-8E80-206558B58BB6Q36871595-E0C65774-49EE-406C-9883-37BE859B7510Q36950478-463598D8-C6C7-4085-85EA-7CE6EF313BB7Q37017111-55F06016-E84C-455E-BA7F-F653147AF65DQ37402657-804CF881-EA82-47C4-880D-63E6EFC729CAQ37792821-4261478F-3190-4CA7-A43C-3303CC1A5473Q38046794-66DD4080-D733-4C67-9709-1ED5C19A46A4Q38799459-A9708DC1-9EA6-4EA4-A21C-F01C7357D410Q42063509-7DE0887E-EFD4-4E15-924A-DC8B3B9E3D02Q44662281-2B099068-E6FA-4521-A287-08A419723389Q45183591-8EDDEB21-39CE-49DE-AD0F-12350F4303F6Q46074266-9D40D2D8-E0F6-4644-B979-720C25EEF654Q46715129-C799E2B4-3908-43A7-82B9-191D12123D3FQ48162367-8CB85CCF-4DBB-4390-9821-1B71958317B6Q50761748-95FC1D6A-DD28-4F7F-A88F-C5A229EB45C8
P2860
Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Detection of leukemia-associat ...... NA topoisomerase II inhibitors
@ast
Detection of leukemia-associat ...... NA topoisomerase II inhibitors
@en
Detection of leukemia-associat ...... NA topoisomerase II inhibitors
@nl
type
label
Detection of leukemia-associat ...... NA topoisomerase II inhibitors
@ast
Detection of leukemia-associat ...... NA topoisomerase II inhibitors
@en
Detection of leukemia-associat ...... NA topoisomerase II inhibitors
@nl
prefLabel
Detection of leukemia-associat ...... NA topoisomerase II inhibitors
@ast
Detection of leukemia-associat ...... NA topoisomerase II inhibitors
@en
Detection of leukemia-associat ...... NA topoisomerase II inhibitors
@nl
P2093
P2860
P3181
P356
P1476
Detection of leukemia-associat ...... NA topoisomerase II inhibitors
@en
P2093
B H Kushner
D G Leonard
E F Rappaport
M D Megonigal
N K Cheung
P C Nowell
P2860
P304
P3181
P356
10.1073/PNAS.050397097
P407
P577
2000-03-14T00:00:00Z